Wellborn Gayle Furgurson 4
4 · HEALTHEQUITY INC · Filed Feb 5, 2018
Insider Transaction Report
Form 4
Wellborn Gayle Furgurson
Director
Transactions
- Award
Common Stock
2018-02-01+1,637→ 4,281 total - Award
Stock Options (right to buy)
2018-02-01+4,339→ 4,339 totalExercise: $50.41Exp: 2028-02-01→ Common Stock (4,339 underlying) - Award
Common Stock
2018-02-01+793→ 5,074 total
Holdings
- 7,736
Stock Option (right to buy)
Exercise: $47.21Exp: 2027-08-01→ Common Stock (7,736 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 818 shares on the date of the issuer's annual stockholder meeting held in the current fiscal year; the remainder will vest on January 31, 2019. Vested shares will be delivered to the reporting person upon vesting.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 198 shares on February 1, 2018. The remaining restricted stock units vest as to 198 shares on May 1, 2018 and August 1, 2018, and as to 199 shares on November 1, 2018. Vested shares will be delivered to the reporting person upon vesting.
- [F3]The option is exercisable as to 2,439 shares. The option becomes exercisable as to the remaining 5,297 shares in three equal annual installments on August 1, 2018, 2019 and 2020.
- [F4]The option becomes exercisable as to 2,169 shares on the date of the issuer's annual stockholder meeting held in the current fiscal year; the remainder will become exercisable on January 31, 2019.